Literature DB >> 8640794

Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas.

D R Haugen1, L A Akslen, J E Varhaug, J R Lillehaug.   

Abstract

c-erbB-3 and c-erbB-4 protein expression was analyzed using immunohistochemistry in 138 fresh-frozen thyroid tissue samples from 106 patients, including 56 cases of papillary thyroid carcinoma. Increased expression of c-erbB-3 and c-erbB-4 proteins was observed in papillary carcinomas compared to nonneoplastic thyroid tissue. No amplifications of the c-erbB-3 and c-erbB-4 genes were detected. Coexisting overexpression of epidermal growth factor receptor, c-erbB-2, c-erbB-3, and c-erbB-4 was demonstrated in 36 (64%) of 56 papillary thyroid carcinomas. These findings suggest a common regulatory mechanism for the type I (epidermal growth factor receptor-related) receptors in papillary thyroid carcinomas and provide numerous possibilities for functional receptor interactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8640794

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

2.  miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.

Authors:  Hongwei Liang; Minghui Liu; Xin Yan; Yong Zhou; Wengong Wang; Xueliang Wang; Zheng Fu; Nan Wang; Suyang Zhang; Yanbo Wang; Ke Zen; Chen-Yu Zhang; Dongxia Hou; Jing Li; Xi Chen
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

3.  Genome-wide meta-analysis identifies novel loci associated with free triiodothyronine and thyroid-stimulating hormone.

Authors:  M Popović; A Matana; V Torlak; T Boutin; D Brdar; I Gunjača; D Kaličanin; I Kolčić; V Boraska Perica; A Punda; O Polašek; M Barbalić; C Hayward; T Zemunik
Journal:  J Endocrinol Invest       Date:  2019-03-07       Impact factor: 4.256

4.  Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.

Authors:  Jorma A Määttä; Maria Sundvall; Teemu T Junttila; Liisa Peri; V Jukka O Laine; Jorma Isola; Mikala Egeblad; Klaus Elenius
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

Review 5.  Emerging therapies in gastrointestinal cancers.

Authors:  Jyoti Nautiyal; Arun K Rishi; Adhip P N Majumdar
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

6.  Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients.

Authors:  Mirza Masroor; Jamsheed Javid; Rashid Mir; Prasant Y; Imtiyaz A; Mariyam Z; Anant Mohan; P C Ray; Alpana Saxena
Journal:  Tumour Biol       Date:  2015-08-09

7.  MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma.

Authors:  Yanhong Qu; Honghong Qu; Manli Luo; Peng Wang; Chunhua Song; Kaijuan Wang; Jianying Zhang; Liping Dai
Journal:  Mol Genet Genomics       Date:  2014-06-12       Impact factor: 3.291

8.  EGF and TGF-β1 Effects on Thyroid Function.

Authors:  Gabriella Mincione; Maria Carmela Di Marcantonio; Chiara Tarantelli; Sonia D'Inzeo; Arianna Nicolussi; Francesco Nardi; Caterina Francesca Donini; Anna Coppa
Journal:  J Thyroid Res       Date:  2011-06-13

9.  c-erbB-4 protein expression in human breast cancer.

Authors:  T Y Kew; J A Bell; S E Pinder; H Denley; R Srinivasan; W J Gullick; R I Nicholson; R W Blamey; I O Ellis
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

10.  MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF.

Authors:  Li-Qiang Wei; Hui-Tao Liang; Dong-Chun Qin; Hui-Fang Jin; Yong Zhao; Ming-Cong She
Journal:  Tumour Biol       Date:  2014-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.